Rajiv Dattatreya, MD FACE

Rajiv Dattatreya, MD, FACE  –  Biography

Dr. Rajiv Dattatreya, originally from India, obtained a medical degree from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India in 1986. He completed an Internal Medicine residency program at Albert Einstein College of Medicine, New York. Subsequently, he completed his Endocrinology fellowship at Cleveland Clinic, Ohio.

Dr. Dattatreya is board certified in Endocrinology, Diabetes, and Metabolism. He specializes in disorders of the Endocrine system, including Thyroid, Diabetes and metabolism, and osteoporosis. He is a Fellow of the American Association of Clinical Endocrinologists (AACE)

In his spare time, Dr. Dattatreya delivers lectures on health-related topics and educates health care professionals. He likes gardening, cooking, and music. He is married, with two teenage children.

Rajiv Dattatreya, MD – Curriculum Vitae

Board Certification

• American Board of Internal Medicine: Endocrinology, Diabetes, and Metabolism 1997
• American Board of Internal Medicine 1995

Hospital Affiliations

Baylor at Irving- Active Staff
Medical City Las Colinas – Active Staff

Professional Experiences

1. Endocrine Associates of Dallas & Plano, Present
2. North Texas Diabetes and Endocrinology of lrving, 2021 N MacArthur Blvd, Ste 225, Irving, Tx- 75061, 07/2018
3. Endocrinology, Diabetes and Metabolism Medical & Surgical Clinic of Irving, PA 2021 N. MacArthur 4/2009 – 04/2009
4. Family Practice, Healthcare Associates of Irving, LLP 1110 Cottonwood Lane, Irving, TX 75038, 4/2007 – 04/2009
5. North Texas Health Care Associates 2021 N. MacArthur Blvd, Irving, TX 75061, 02/2002 – 04/2007
6. Diabetes Center of Southwest 10 Desta Drive, Midland, TX 79705, 09/2000 – 02/2002
7. Multi-Specialty Medical Group 111 Coastal Way, Chesapeake, VA 23320, 03/1998 – 08/2000
8. Multi-Specialty Medical Group Route 168 & Courthouse Rd Currituck, NC, 03/1998 – 08/2000
9. Gap due to move to USA, vacation, 02/1992 – 06/1992
10. St. Luke’s Hospital, Bradford, West Yorkshire, UK, 08/1991-01/1992
11. Bradford Royal Infirmary Bradford, West Yorkshire, UK, 04/1991 – 07/1991
12. Wrightington Hospital Wigan, Lancashire, UK, 08/1990-01/1991
13. Severalls Hospital Colchester, Essex, UK 07/1990-08/1990
14. St. Mary’s Hospital, Essex, UK, 04/1990 – 06/1990

Professional Organization Memberships

• American Association of Clinical Endocrinologists (AACE)
• Texas Medical Association 2021
• Dallas County Medical Society 202

Education

Rotating Internship

Jawaharlal Institute of Postgraduate Medicine Education & Research
Pondicherry, India 605 006, 05/1986 – 12/1986

Internal Medicine

Postgraduate Institute of Medical Education & Research Sector 12
Chandigarh, India 160 012, 01/1987 – 01/1990

Gap due to preparation and writing of the Professional and Linguistic Assessments Board Examination (PLAB), 02/1990 – 03/1990

Internal Medicine Residency

Albert Einstein College of Medicine of Yeshiva University 1300 Morris Park Ave., Bronx, NY I 0461, 07/1992-06/1995

Endocrinology Fellowship

Endocrinology Fellowship Cleveland Clinic Foundation 9500 Euclid Ave #EE46 Cleveland, OH 44195, 07/11/995 – 06/11/997

Medical Awards, Licensure, and Certifications

• Texas State Board License 2000
• American Board of Internal Medicine 1995
• American Board of Internal Medicine Endocrinology 1997, Recertification 2007 and 2017
• Fellow, AACE 2002

Research and Publications

Poster Presentation

“Effect of Radioactive Iodine Treatment on Grave’s Ophthalmopathy,” American Thyroid Association meeting, Colorado Springs, Colorado, 1997

Research- Phase II-IV Studies

Short Term, Multicenter, Randomized, Open-Label, Parallel-Group Study Assessing the Pulmonary Effects of Chronically Dosed Inhaled or Subcutaneous Insulin Therapy. Pfizer A2171027

Efficacy and Safety of Exubera (inhaled insulin) Compared with Subcutaneous Human Insulin Therapy in Adult Subject with Type-2 Diabetes Mellitus:
A Two -year, Outpatient, Open-Label, Parallel-Group Comparative Trial. Pfizer A2171029

A Multi-national, Randomized, Double-blind, Placebo-Controlled, Force Titration, 2×2 Factorial Design Study of the Efficacy and Safety of Long Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance (IGT). Novartis CDJN608B2302

Publication

Effect of 131 Iodine Therapy on the Course of Graves’ Ophthalmopathy:
A Quantitative Analysis of Extraocular Muscle Volumes Using Orbital Magnetic Resonance Imaging, Thyroid: 2001.

Speaker’s Bureau

AbbVie, Astra-Zeneca, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk Sanofi.